Clinical trial
Evaluation of the Persistence of the Complete Molecular Remission After Stopping…
NCT00478985 · University Hospital, Bordeaux, Other · Completed
Key facts
| NCT number | NCT00478985 |
|---|---|
| Title | Evaluation of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia |
| Official title | Evaluation of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia (STIM) |
| Acronym | STIM |
| Lead sponsor | University Hospital, Bordeaux, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Myeloid Leukemia, Chronic |
| Intervention type | Behavioral |
| Interventions | Imatinib ending |
| Enrollment | 100 |
| Start date | Jun 1, 2007 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | May 25, 2007 |
| Last update posted | Jul 2, 2013 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: